In vitro study reveals antileishmanial activity of new γ-butyrolactone derivatives from Cophinforma mamane, suggesting potential scaffolds for antiparasitic drug development.
High Resolution Image Download MS PowerPoint Slide From an endophytic strain of Cophinforma mamane isolated from the leaves of Bixa orellana, a previously undescribed γ-butyrolactone compound ( 2 ) and three new cyclopentapeptides ( 3 - 5 ) have been isolated from the same strain, along with the known (4 R) -striatisporolide A ( 1 ). Their structures were elucidated through extensive spectral analysis and DP4+ calculations. The two γ-butyrolactone derivatives ( 1, 2 ) exhibited moderate inhibitory activity against axenic Leishmania infantum amastigotes (IC 50 = 13.33 and 4.43 μM, respectively), while only compound 2 displayed cytotoxic activity on Jurkat cells (17% growth inhibition at 1 μg/mL) and weak antibacterial activity against Enterococcus faecalis (MIC = 64 μg/mL).
No takes yet. Share an insight, caveat, or question.
Litot et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: